Oligoncleotide analogues: An overview

CIBA Foundation Symposia

Volumn , Issue 209, 1997, Pages 5-18

  Matteucci, Mark ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ANIMAL; CHEMISTRY; HUMAN; REVIEW;

ANIMALS; HUMANS; OLIGONUCLEOTIDES;

EID: 0031303283     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Altmann KH, Dean NM, Fabbro D et al 1996 Second generation of antisense oligonucleotides: from nuclease resistance to biological efficacy in animals. Chimia 50:168-176
2. Bennett CF, Chiang M-Y, Chan H, Shoemaker JE, Mirabelli CK 1992 Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotide. Mol Pharmacol 41:1023-1033
3. Bonham MA, Brown S, Boyd AL et al 1995 An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res 23:1197-1203
4. Buhr CA, Wagner RW, Grant D, Froehler BC 1996 Oligodeoxynucleotides containing C-7 propyne analogs of 7-deaza-2′-deoxyguanosine and 7-deaza-2′-deoxyadenosine. Nucleic Acids Res 24:2974-2980
5. kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880
6. Cohen JS 1993 Phosphorothioate oligodeoxynucleotides. In: Crooke ST, Lebleu B (eds) Antisense research, applications. CRC Press, Boca Raton, FL, p 205-221
7. De Mesmaeker AD, Häner R, Martin P, Moser HE 1995 Antisense oligonucleotides. Acc Chem Res 28:366-374
8. Dempcy RO, Browne KA, Bruice TC 1995 Synthesis of thymidyl pentamer of deoxyribonucleic guanidine and binding studies with DNA homopolynucleotides. Proc Natl Acad Sci USA 92:6097-6101
9. Escudé C, Giovannangeli C, Sun J-S et al 1996 Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation. Proc Natl Acad Sci USA 93:4365-4369
10. Flanagan WM, Su L, Wagner RW 1996 Elucidation of gene function using C-5 propyne antisense oligonucleotides. Nat Biotechnol 14:1139-1145
11. Froehler BC, Wadwani S, Terhorst TJ, Gerrard SR 1992 Oligodeoxynucleotides containing C-5 propyne analogs of 2′-deoxyuridine and 2′-deoxycytidine. Tetrahedron Lett 33:5307-5310
12. Gryaznov S, Schultz RG 1994 Stabilization of DNA:DNA and DNA:RNA duplexes by substitution of 2′-deoxyadenosine with 2′-deoxy-2′-aminoadenosine. Tetrahedron Lett 35:2489-2492
13. Gryaznov S, Skorski T, Cucco C et al 1996 Oligonucleotide N3′→P5′ phosphoramidates as antisense agents. Nucleic Acids Res 24:1508-1514
14. Haaima G, Lohse A, Buchardt O, Nielsen PE 1996 Peptide nucleic acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-lysine PNA. Angew Chem Int Ed Engl 35:1939-1942
15. Inoue H, Hayase Y, Imura A, Iwai S, Miura K, Ohtsuka E 1987 Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides. Nucleic Acids Res 15:6131-6148
16. Kawasaki AM, Casper MD, Freier SM et al 1993 Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem 36:831-841
17. Knudsen H, Nielsen PN 1996 Antisense properties of duplexand triplex-forming PNAs. Nucleic Acids Res 24:494-500
18. Leonetti JP, Mechti N, Degols G, Gagnor C, Lebleu B 1991 Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci USA 88:2702-2706
19. Lewis JG, Lin K-Y, Kothavale A et al 1996 A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA 93:3176-3181
20. Lin K-Y, Jones RJ, Matteucci M 1995 Tricyclic 2′-deoxycytidine analogs: syntheses and incorporation into oligodeoxynucleotides which have enhanced binding to complementary RNA. J Am Chem Soc 117:3873-3874
21. Marshall WS, Caruthers MH 1993 Phosphorodithioate DNA as a potential therapeutic drug. Science 259:1564-1570
22. Miller PS 1991 Oligonucleoside methylphosphonates as antisense reagents. Biotechnology 9:358-365
23. Monia BP, Johnston JF, Sasmor H, Cummins LL 1996a Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J Biol Chem 271:14533-14540
24. Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D 1996b Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2:668-675
25. Reynolds MA, Hogrefe RI, Jaeger JA 1996 Synthesis and thermodynamics of oligonucleotides containing chirally pure Rp methylphosphonate linkages. Nucleic Acids Res 24:4584-4591
26. Sanghvi YS 1993 Heterocyclic base modifications in nucleic acids and their applications in antisense oligonucleotides. In: Crooke ST, Lebleu B (eds) Antisense research, applications. CRC Press, Boca Raton, FL, p 273-288
27. Schultz RG, Gryaznov SM 1996 Oligo-2′-fluoro-2′-deoxynucleotide N3′→P5′ phosphoramidates: synthesis and properties. Nucleic Acids Res 24:2966-2973
28. Seela F, Thomas H 1995 Duplex stabilization of DNA: oligonucleotides containing 7-substituted 7-deazaadenines. Helv Chim Acta 78:94-97
29. Shoji Y, Akhtar S, Periasamy A, Herman B, Juliano R 1991 Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphate linkages. Nucleic Acids Res 19:5543-5550
30. Sood S, Shaw RB, Spielvogel BF 1991 Boron-containing nucleic acids. Synthesis of oligonucleoside boranophosphates. J Am Chem Soc 112:9000-9001
31. Summerton J, Stein D, Huang SB, Matthews P, Weller D, Partridge M 1997 Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems. Antisense Nucleic Acid Drug Dev 7:63-70
32. Van Aerschot A, Verheggen I, Hendrix C, Herdewijn P 1995 1,5-Anhydrohexitol nucleic acids, a new promising antisense construct. Angew Chem Int Ed Engl 34:1338-1340
33. Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C, Froehler BC 1993 Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260:1510-1513
34. Wagner RW, Matteucci MD, Grant D, Huang T, Froehler BC 1996 Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nat Biotechnol 14:840-844
35. Wyatt JR, Vickers TA, Roberson JL et al 1994 Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci USA 91:1356-1360